Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

plitidepsin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Other hematologic neoplasm 2 Lymphoid 2 Sarcoma 1 Genitourinary 1

Conditions

Recurrence 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Cyclophosphamide 191 Radiotherapy 188 Doxorubicin 182 Temozolomide 162 Ifosfamide 104 Filgrastim 97 Imatinib Mesylate 92 Etoposide 88 Vincristine 81 Gemcitabine 75 Bevacizumab 72 Irinotecan 69 Magnetic Resonance Spectroscopy 66 pembrolizumab 61 Radiation 60 Carboplatin 56 Methotrexate 53 pazopanib 52 fludarabine phosphate 50 Trabectedin 49 Cisplatin 49 Specimen Handling 48 Nivolumab 47 Peripheral Blood Stem Cell Transplantation 46 Biopsy 45 Surgical Procedures, Operative 43 Docetaxel 43 Busulfan 43 Melphalan 42 Paclitaxel 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡